Associated Papers
Extended clinical phenotypes and treatment modalities in 32 JAGN1-deficient patients: a multicenter study by ESID and EBMT IEWP.
Fekadu-Siebald J et al.
Blood Advances, 2025
JAGN1 mutation with distinct clinical features; two case reports and literature review.
Hojabri M et al.
Bmc Pediatrics, 2023
Ciliary and immune dysfunctions and their genetic background in patients with non-cystic fibrosis bronchiectasis in Central Iran.
Hassanzadeh S et al.
Irish Journal of Medical Science, 2023
Severe congenital neutropenia due to jagunal homolog 1 (JAGN1) mutation: a case report and literature review.
Thomas S et al.
Frontiers in Pediatrics, 2023
A crucial role for Jagunal homolog 1 in humoral immunity and antibody glycosylation in mice and humans.
Hagelkruys A et al.
The Journal of Experimental Medicine, 2021
Severe congenital neutropenia-associated JAGN1 mutations unleash a calpain-dependent cell death programme in myeloid cells.
Khandagale A et al.
British Journal of Haematology, 2021
A rare case of syndromic severe congenital neutropenia: JAGN1 mutation.
Çipe FE et al.
The Turkish Journal of Pediatrics, 2020
JAGN1 is required for fungal killing in neutrophil extracellular traps: Implications for severe congenital neutropenia.
Khandagale A et al.
Journal of Leukocyte Biology, 2018
Gene mutations responsible for primary immunodeficiency disorders: A report from the first primary immunodeficiency biobank in Iran.
Sheikhbahaei S et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology, 2016
JAGN1 deficiency causes aberrant myeloid cell homeostasis and congenital neutropenia.
Boztug K et al.
Nature Genetics, 2014
HAX1 mutation in an infant with severe congenital neutropenia.
Eghbali A et al.
The Turkish Journal of Pediatrics, 0
Select a paper to view details